Clinical Trial

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 8, 2024 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to investigate the efficacy of NMN supplementation in enhancing embryo developmental capacity and improving IVF success rates in patients experiencing IVF failures.
Trial Details
NCT Number NCT06629636
Lead Sponsor Sunkaky Medical Cooperation
Collaborators: Abinopharm, Inc, Aba Chemicals Co Ltd
Conditions Repeated IVF Failure, Female Infertility
Enrollment 60 participants
Start Date 2024-08-20
Primary Completion 2025-09-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-08